Assembly Biosciences (ASMB) Current Leases (2019 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Current Leases of $590000.0 in Q1 2026, up 3.69% quarter-over-quarter from $569000.0 in Q4 2025, and up 11.53% on a YoY basis from $529000.0 in Q1 2025.
Assembly Biosciences (ASMB) Current Leases (2019 - 2026) Analysis & Trends
Assembly Biosciences' Current Leases history runs 8 years deep, the most recent figure standing at $590000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 11.53% year-over-year to $590000.0; the TTM figure through Mar 2026 stood at $590000.0 (up 11.53% YoY), while the FY2025 annual figure was $569000.0, up 23.43% from the prior year.
- Current Leases was $590000.0 for Q1 2026 at Assembly Biosciences, up from $569000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.4 million in Q3 2022 to a low of $461000.0 in Q4 2024.
- Historically, Current Leases has averaged $1.6 million across 5 years, with a median of $1.2 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Current Leases slumped 74.22% in 2023, then soared 52.93% in 2024.
- A 5-year view of Current Leases shows it stood at $3.4 million in 2022, then sank by 63.73% to $1.2 million in 2023, then plunged by 62.21% to $461000.0 in 2024, then gained by 23.43% to $569000.0 in 2025, then rose by 3.69% to $590000.0 in 2026.
- The last three Current Leases figures came in at $590000.0 (Q1 2026), $569000.0 (Q4 2025), and $548000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 590,000.00 |
| Dec 31, 2025 | 569,000.00 |
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 529,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 869,000.00 |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.10 Mn |
| Jun 30, 2021 | 3.05 Mn |